One gram of omega-3 per day may slow down the rate of biological aging

Al­ly Bridge Group, whose re­cent suc­cess­es in­clude CG On­col­o­gy‘s eye-pop­ping IPO, said it pro­mot­ed two peo­ple to head up its pri­vate eq­ui­ty strate­gies across biotech

Fate Therapeutics’ current president of research and development, Bob Valamehr, will take over as president and CEO effective from 1 January 2025. Credit: Piotr Swat/Shutterstock.

Patients with highly active systemic lupus erythematosus (SLE) appeared to sustain much less organ damage and fewer disease flares when drug therapy yielded substantial relief,